A prospective clinical trial of D‐penicillamine in the treatment of primary biliary cirrhosis
Henry C. Bodenheimer, Fenton Schaffner, Irmin Sternlieb, Franklin M. Klion, Salvatore Vernace, John Pezzullo – 1 November 1985 – We conducted a prospective clinical trial to assess the relative efficacy and safety of high‐ vs. low‐dose D‐penicillamine in patients with primary biliary cirrhosis. Following clinical tests and liver biopsy diagnostic of primary biliary cirrhosis, 56 patients were randomized to receive either 250 or 750 mg D‐penicillamine daily. Patients were monitored with clinical tests and annual liver biopsy.